I suspect you would not be losing faith in the company if the share price was at 98c and not 58c. People anchor themselves to the share price. SP for VLA news driven like most biotechs. News has been ok so far....we wait for more. The value of VLA lies in its clinical results. As I have said, there are lots of people suggesting the SP should be a lot higher with the clinical results already released to date.
Add to My Watchlist
What is My Watchlist?